Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit

被引:5
|
作者
Weiss, Katja [1 ]
Simon, Arne [1 ]
Graf, Norbert [1 ]
Schoepe, Jakob [2 ]
Oertel, Joachim [3 ]
Linsler, Stefan [3 ]
机构
[1] Univ Hosp Childrens Clin, Paediat Oncol & Haematol, D-66421 Homburg, Saar, Germany
[2] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Campus Homburg, Homburg, Saar, Germany
[3] Univ Saarland, Univ Hosp, Sch Med, Dept Neurosurg, Kirrbergerstr Bldg 90, D-66421 Homburg, Saar, Germany
关键词
Paediatric oncology; Neurosurgery; Perioperative antimicrobial prophylaxis; Quality improvement in health care; SURGICAL ANTIBIOTIC-PROPHYLAXIS; HEALTH-CARE; INFECTIONS; HOSPITALS; CHILDREN; SURGERY; STEWARDSHIP; MENINGITIS; CRANIOTOMY; PREVENTION;
D O I
10.1007/s00381-016-3279-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Perioperative antimicrobial prophylaxis (PAP) has been identified as an important target for internal audits, concerning the judicious use of antibiotics. Paediatric oncology patients with brain tumours face an increased risk of surgical site infection (SSI) after neurosurgery and receive routine PAP in this setting. All patients younger than 18 years admitted to the paediatric oncology centre (POC) with a neurosurgical intervention. Systematic audit of routine clinical data is divided in two groups: retrospective (Jan 01, 2012-March 31, 2014) and prospective (April 01, 2014-March 31, 2015) referring to an internal PAP guideline, invented in Jan. 2014). Surveillance of SSI up to 30 days after the operation with standard criteria (Centres for Disease Control and Prevention, USA). In total, 53 neurosurgical operations were analysed in 33 paediatric oncology patients. Twelve patients received more than one operation. The detailed analysis of PAP revealed prophylactic cefuroxim doses about 30 mg/kg instead of 50 mg/kg and no repeated dosing in operations lasting longer than 4 h. In addition, Cefotaxim, which is not indicated as PAP in neurosurgery, was used instead of Cefuroxim (or Ampicillin-Sulbactam) in 23 % of all cases in the retrospective and 18 % of all cases in the prospective audit. PAP for more than 3 doses (> 24 h) was administered in 66 % in the retrospective group and in 60 % in the prospective group (p = n.s.). In both groups, no SSI was detected. This first comprehensive audit of PAP in paediatric oncology patients undergoing neurosurgery outlines significant opportunities to improve clinical practice in terms of correct dosing, the correct choice of the antibiotic, a correct timing schedule and a shorter duration of PAP. In addition, our results illustrate in detail the challenges in clinical practice when an evidence-based approach to improve a standard workflow has to be implemented.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 50 条
  • [31] The Role of a Clinical Research Nurse: A Narrative Review of the Role in a National Paediatric Haematology/Oncology Unit
    Olalia, R.
    Mc Loughlin, S.
    Rooney, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S217 - S217
  • [32] DOCTOR- PATIENT COMMUNICATION IN PAEDIATRIC ONCOLOGY UNIT FROM THE PATIENT AND PARENTS PERSPECTIVE
    Jankowska, Katarzyna
    Kurylak, Andrzej
    Mariusz, Wysocki
    Pagan, Izabela
    Wojikiewicz, Magdalena
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 853 - 853
  • [33] Time to drop the phenylephrine from the paediatric cycloplegia protocol: informing practice through audit
    Llewellyn, Sue
    Khandelwal, Payal
    Glaze, Selina
    Thomas, Peter
    Dahlmann-Noor, Annegret
    EYE, 2019, 33 (02) : 337 - 338
  • [34] Time to drop the phenylephrine from the paediatric cycloplegia protocol: informing practice through audit
    Sue Llewellyn
    Payal Khandelwal
    Selina Glaze
    Peter Thomas
    Annegret Dahlmann-Noor
    Eye, 2019, 33 : 337 - 338
  • [35] Experience Concerning Paediatric Palliative Care in Hemato-Oncology: Lessons from the Past for the Future
    Renard, M.
    Ruysseveldt, I.
    Labarque, V.
    Jacobs, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S284 - S284
  • [36] Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'
    Langenberg, Karin P. S.
    Meister, Michael T.
    Bakhuizen, Jette J.
    Boer, Judith M.
    van Eijkelenburg, Natasha K. A.
    Hulleman, Esther
    Ilan, Uri
    Looze, Eleonora J.
    Dierselhuis, Miranda P.
    van der Lugt, Jasper
    Breunis, Willemijn
    Schild, Linda G.
    Ober, Kimberley
    van Hooff, Sander R.
    Scheijde-Vermeulen, Marijn A.
    Hiemcke-Jiwa, Laura S.
    Flucke, Uta E.
    Kranendonk, Mariette E. G.
    Wesseling, Pieter
    Sonneveld, Edwin
    Punt, Simone
    Boltjes, Arjan
    van Dijk, Freerk
    Verwiel, Eugene T. P.
    Volckmann, Richard
    Hehir-Kwa, Jayne Y.
    Kester, Lennart A.
    Koudijs, Marco M. J.
    Waanders, Esme
    Holstege, Frank C. P.
    Vormoor, H. Josef
    Hoving, Eelco W.
    van Noesel, Max M.
    Pieters, Rob
    Kool, Marcel
    Stumpf, Miriam
    Blattner-Johnson, Mirjam
    Balasubramanian, Gnana P.
    Van Tilburg, Cornelis M.
    Jones, Barbara C.
    Jones, David T. W.
    Witt, Olaf
    Pfister, Stefan M.
    Jongmans, Marjolijn C. J.
    Kuiper, Roland P.
    de Krijger, Ronald R.
    Wijnen, Marc H. W.
    den Boer, Monique L.
    Zwaan, C. Michel
    Kemmeren, Patrick
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 311 - 325
  • [37] Clinical value of stool culture in paediatric oncology patients: hospital evaluation and UK survey of practice
    O'Connor, O.
    Cooke, R. P. D.
    Cunliffe, N. A.
    Pizer, B.
    JOURNAL OF HOSPITAL INFECTION, 2017, 95 (01) : 123 - 125
  • [38] The Psychological Needs of Haematology and Oncology Patients in a Paediatric Palliative Care Perspective: Clinical Audit and Service Development in Ireland
    Besani, C.
    O'reilly, M.
    Twomey, M.
    Devins, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S275 - S275
  • [39] Cardiovascular Drug Therapy in Paediatric Age: From Metabolomics to Clinical Practice
    Bassareo, Pier Paolo
    Fanos, Vassilios
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (27) : 3107 - 3107
  • [40] Service Evaluation of the Clinical Value of Routinely Testing Stools for Rotavirus Antigen in a Regional Paediatric Oncology Unit
    Akhtar, T.
    Cargill, J.
    Gerrard, C.
    Shaw, F.
    Cunliffe, N.
    Cooke, R.
    Pizer, B.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S374 - S374